相关实验视频
Updated: May 20, 2025

06:40
Biofunctionalization of Magnetic Nanomaterials
Published on: July 16, 2020
2.5K
针对铁稳态的纳米材料:癌症治疗的有希望的策略
Bin Li1, Bing Zhang2, Ziyue Cheng1
1Institute of Urology, Zhong Da Hospital, Southeast University School of Medicine, Nanjing, China.
Frontiers in bioengineering and biotechnology
|March 27, 2025
概括
瘤细胞需要高水平的铁来生长,使铁代谢成为癌症治疗的目标. 基于纳米技术的铁化剂提供了一种有前途的策略,可以破坏瘤的铁吸收并对抗癌症的进展.
科学领域:
- 生物化学 生物化学
- 在瘤学瘤学.
- 纳米技术纳米技术
背景情况:
- 铁对细胞功能至关重要,如DNA合成和增殖.
- 癌细胞表现出高铁吸收,由转移素受体驱动,以支持快速生长和转移.
- 细胞内铁储存在费里 (重链和轻链) 中,或存在于性铁池中.
研究的目的:
- 审查纳米技术的最新进展,以准癌细胞的铁代谢.
- 讨论铁向纳米载体在癌症治疗策略中的潜力.
主要方法:
- 基于纳米技术的药物输送系统的探索,其中包括转移蛋白.
- 在纳米载体中封装的铁合剂 (Deferoxamine,Deferasirox,DP44mT) 的研究.
- 分析这些药物如何在瘤细胞中诱导缺铁.
主要成果:
- 转林结合的纳米载体在药物敏感癌细胞中增强了细胞毒性作用.
- 通过纳米载体输送的铁化剂在瘤中减少细胞内铁的承诺.
- 准铁代谢为癌症治疗提供了一个新的治疗途径.
结论:
- 纳米技术提供了创新的方法来操纵癌细胞的铁代谢.
- 通过纳米载体输送的铁合剂代表了克服当前癌症治疗局限性的潜在策略.
- 对这些纳米药物的进一步研究可能会导致改善癌症治疗结果.
相关概念视频
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
Drugs that Stabilize Microtubules
2.0K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.0K
Electron Transport Chain: Complex I and II
9.8K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
9.8K

